Follow us...


Search News Archives





View Channel

Laboratory Products



View Channel

Special Offers and Promotions


Microscopy | Image Analysis



View Channel

Separation Science



View Channel

Coronavirus (COVID-19)



View Channel

Research & Case Studies



View Channel

Conferences | Events

Oxford Global’s Q&A Session with Drug Discovery USA Speaker Matthew Wagoner, a Discovery Safety Specialist from AstraZeneca

publication date: Sep 10, 2015
author/source: Oxford Global

oxford global drug discovery

In the run up to our 2nd Annual Drug Discovery USA Congress 2015, we spoke with Matthew Wagoner a discovery safety specialist from AstraZeneca, a confirmed speaker at the congress where he will talk about Bromodomain And ExtraTerminal (BET) Domain Inhibitors Induce A Loss Of Intestinal Stem Cells And Villous Atrophy.

Big Pharma is keen to increase drug discovery productivity; which strategies do you think will help to increase R&D output?

“I think the strategies for increasing drug discovery productivity will be multifaceted. We do quite a bit of the traditional internal repurposing and rescue, which is a great way of accelerating a nascent project idea with more advanced chemistry. The most promising of these approaches, in my opinion, is opening up your pharmacology toolbox and clinical compound bank to academics so they can test their best hypotheses with our best molecules. AstraZeneca has done that with great success through the NIH/NCATS and MRC, with 10+ clinical and translational research projects being initiated in academia with AstraZeneca’s patient-ready compounds.”

Read the full interview

The 2nd Annual Drug Discovery USA Congress is taking place on the 29th & 30th of October 2015 in Boston, USA. Over 150 senior delegates will represent global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions. The conference will provide over 40 presentations and case studies focusing on the key issues in drug discovery and medicinal chemistry.

Register your interest today to hear over 40 presentations, case studies and panel discussions across 4 interactive streams:

  • Target Based Discovery
  • Screening & Assays: Enabling Technologies
  • Discovery Chemistry & Drug Design
  • Supporting Innovation: Translational Approaches & Informatics Tools

Download the conference programme to find out more about this two day congress
What is included in your package?
  • Full access to the 2 days of conference presentationsLunch and refreshments during the congress
  • Access to all networking activities
  • Access to exhibition area

Registration to attend the 2nd Annual Drug Discovery USA Congress is now open. For further information on booking your place today, or to find out more regarding prices and discounts, please contact Guillaume Alonso on or call +44 (0)1865 248455 to request further information regarding the Congress or to receive a promotional code.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month


Today's Picks




Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners